Dorry L. Segev, MD, PhD
Marjory K. and Thomas Pozefsky Professor of Surgery and Epidemiology
Associate Vice Chair, Department of Surgery
Director, Epidemiology Research Group in Organ Transplantation
Johns Hopkins University
- Councilor-at-Large (2015 – 2018)
- Chair, Pipeline Task Force (2018 – present)
- Chair, PROACTOR Task Force (2015 - 2017)
- Chair, ATC Executive Planning Committee (2013 – 2015)
- Member, Grants Review Committee (2013 – 2015)
- Co-Chair, ATC Executive Planning Committee (2012 – 2013) Chair, Vanguard Committee (2010 – 2013)
- Work Group Leader, KPD Joint Consensus Conference (March 2012)
- Work Group Leader, Increased Risk Donor Joint Consensus Conference (April 2012)
- Co-Chair Elect, ATC Executive Planning Committee (2011 – 2012)
- Co-Chair, Testing of Live Donors to Prevent Transmission of Infectious Diseases Joint Consensus Conference (July 2011)
- Member, ATC Planning Committee (2012 -2015)
- Co-Chair, Vanguard Committee (2009 – 2010)
- Member, Program Specific Reports Task Force (2009 – 2010)
- Member, Vanguard Committee (2008 – 2009)
- Member, Kidney Allocation Task Force (2008 – 2009)
- Recipient, ASTS Pfizer Mid-Level Faculty Grant (2012 - 2014)
- Recipient, ASTS Vanguard Prize (2006)
- Recipient, ASTS Novartis Fellowship in Transplantation Award (2004 – 2006)
I am delighted to be nominated for President-Elect of our Society. I have contributed extensively and consistently to ASTS leadership, including chairing two committees, chairing two task forces, spearheading two congressional bills, and serving as Councilor. I have attended every council/chair meeting for the past decade, and this recent experience is critical for the accelerated 1-year track to President. Additionally, I bring to ASTS considerable leadership and mentorship experience, including building and leading a 100-person research enterprise.
In every role I have served for ASTS, an overarching theme has been attracting young people to transplantation while fostering the success of those already committed to the field. As Vanguard Chair, we identified funding and publication challenges for junior transplant surgeons, leading to expanded ASTS-funded research awards and academic opportunities for junior faculty. As ATC Chair, I created the standing-room-only trainee afternoon, which I still lead, to teach young people about the science and allure of our field. As Councilor, I developed the Pipeline Task Force, and as founding Pipieline Chair, we have already created several initiatives to engage trainees with our field, including: a collaboration with Behind the Knife, a study of resident experiences in transplant surgery, and a new Pipeline Award. I will continue this structural work to keep our field and our society rich and vibrant.
Another theme has been increasing organ availability and utilization; I was the founding Chair of the PROACTOR Task Force with this mission. My research has also focused on expanding transplantation, including developing the Live Donor Champion program, developing clinical decision-making tools to help weigh the risks/benefits of organ acceptance, and advancing incompatible kidney transplantation. I was substantially involved in two major Congressional legislative successes, initiating, writing, and linking ASTS to advocacy groups to move both the Norwood Act (legalizing kidney exchange) and the HOPE Act (legalizing HIV-to-HIV transplants) past the finish line and into clinical practice. I will continue advocating for legislation that will serves our patients and expands our opportunities to save lives.
My background in Computer Science, Electrical Engineering, Music from Rice University, MHS/Biostatistics, MD/PhD from Hopkins gives me a unique perspective on our field. I have published >450 research articles, many of which have led to changes in practice or policy. I am strongly committed to mentorship, with >250 publications involving a mentee as first and/or last author. Many of my mentees are from other institutions, collaborations that were fostered through ASTS. I will continue bringing this spirit of discovery and mentorship to ASTS.
If given the opportunity to lead the ASTS, my priorities would include increasing deceased donor organ availability through optimizing OPO performance and center utilization; increasing living donation through public education, protection from adverse sequelae, and financial neutrality; and improving longevity of transplants through ASTS organizational support of collaborative research. I would work to remove duplicative regulations that stifle innovation in the use of non-ideal donors. Finally, I would continue improving the transplant trainee experience and engaging with medical student and general surgery societies, continuing my efforts to expand the pipeline for new talent into our fascinating field.
I am tremendously committed to this society, and would be honored to have your vote for President-Elect.